Today, the question is not simply how to live longer, but how to live healthier longer.

Your Health / Our Vision / Learn More

AFAR and COVID-19:

To protect the Vulnerable,
We must protect the Science
.

AFAR values Older Americans,
trusts Scientists, and
salutes Geriatricians.

A COVID-19 Message and Resources from AFAR
Mask Older Man

Recent Webinars

Vaccine Masks smaller

The Biology of Aging and Our Body's Readiness for COVID-19 Vaccines

Watch a recording here
I Stock 1213784453 copy 2

Keep it Moving—Immune Health, Muscle Strength, and Exercise

Watch a recording here

AFAR Experts in the News

AFAR News
Ask the Expert Interview: James Kirkland, MD, PhD, on senescence research, early and expanded senolytics, geroscience, and translation
News Item Logo Newsweek
Experts in the News: Multiple AFAR experts in Newsweek on revitalizing search for Alzheimer’s prevention
Considerable News Item Logo9
Grantee in the News: Malaz Boustani on OTC drugs’ side effects and cognitive changes in older adults in Considerable
News Item Logo Nature 2
Board Member in the News: Nature cover story by David Sinclair and AFAR experts on reprogramming to recover youthful epigenetic information and restore vision in mice
News Item Logo Template Next Avenue jpg copy 2
Grantee in the News: Sharon Inouye selected as Next Avenue 2020 Influencer in Aging
News Item Logo MSN
Grantee in the News: Sean Leng on how inflammation, “cytokine storms,” and the connection between COVID-19 and the 1918 Spanish Influenza in MSN

AFAR's Mission

To advance and support healthy aging through biomedical research

Thanks to the science AFAR supports, we are making constant progress toward a simple and compelling vision: the ability for all of us to live healthier each and every day of our lives.

Explore AFAR's Initiatives
WATCH: our 4 minute animation on the impact of aging research, created with the Glenn Foundation for Medical Research and acclaimed data journalist David McCandless

40

Years

4240

Talented Investigators

$

184

Million Funded

Green Spotlight Microscope

Investing in Talent

Novel Interventions

Believing in Innovation

The TAME Trial

The AFAR-managed TAME (Targeting Aging with Metformin) Trial will establish a proof-of-concept that aging processes can be treated, just as we treat diseases.

The TAME Trial ultimately seeks the FDA to make aging an "indication" for treatment.

If aging is made an indication, the TAME Trial will mark a paradigm shift: from treating each age-related medical condition separately, to treating these conditions together, by targeting aging per se.

Learn About the TAME Trial

Stay Connected

For updates on AFAR grantees, events, articles, and more, subscribe to our newsletter, EncourAGE.

Sign Up for Updates
2 Column Card Nir Lab Book Cover web

Age Later: Healthspan, Lifespan, and the New Science of Longevity

New book by AFAR Scientific Director Nir Barzilai, MD

Out Now!

Building Networks and Collaborative Research

AFAR serves as the Coordinating Center for three initiatives funded by the National Institute on Aging.

NSC Whitebox

Providing leadership in the pursuit of basic research into the biology of aging

RCCN White Box

Catalyzing cross-disciplinary research across the NIA center programs

Clin STAR White Box

A national platform to advance transdisciplinary aging research

A Healthier Tomorrow
Starts Today

AFAR-supported investigators are advancing research that will move from the labs into our lives. Join us as we embark on the next frontier of health aging.

Why support Aging Research : Why Support AFAR

AFAR is grateful for collaboration and support of our program partners, including:

Gilbert Whitebox4
Glenn Whitebox5
NAM White Box
NIA Whitebox

AFAR is proud to consistently receive the highest ratings from respected charity evaluators

Charity Nav Whitebox6
Guidestar Whitebox7